Your browser doesn't support javascript.
loading
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
Decaens, Thomas; Barone, Carlo; Assenat, Eric; Wermke, Martin; Fasolo, Angelica; Merle, Philippe; Blanc, Jean-Frédéric; Grando, Véronique; Iacobellis, Angelo; Villa, Erica; Trojan, Joerg; Straub, Josef; Bruns, Rolf; Berghoff, Karin; Scheele, Juergen; Raymond, Eric; Faivre, Sandrine.
Afiliação
  • Decaens T; University Grenoble Alpes, Department of Hepato-Gastroenterology and Digestive Oncology, CHU Grenoble Alpes, Institute for Advanced Biosciences INSERM U1209, Grenoble, France. tdecaens@chu-grenoble.fr.
  • Barone C; Medical Oncology, Policlinico Universitario A. Gemelli, Roma, Italy.
  • Assenat E; Medical Oncology, CHU Saint Eloi, Montpellier, France.
  • Wermke M; NCT/UCC Early Clinical Trial Unit, University Hospital Carl-Gustav-Carus, Dresden, Germany.
  • Fasolo A; Oncology, IRCCS San Raffaele, Milan, Italy.
  • Merle P; Service d'Hépato-Gastro-Entérologie, Hôpital de la Croix Rousse, Lyon, France.
  • Blanc JF; Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Groupe Hospitalier Haut-Lévêque, CHU Bordeaux, Pessac, France.
  • Grando V; Service Hépatologie, Hôpital Jean-Verdier, Bondy, France.
  • Iacobellis A; Reparto di Gastroenterologia ed Endoscopia Digestiva, Ospedale Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo, Italy.
  • Villa E; Division of Gastroenterology Policlinico di Modena, Modena, Italy.
  • Trojan J; Gastrointestinal Oncology, Goethe University Hospital, Frankfurt, Germany.
  • Straub J; Clinical Biomarker & Companion Diagnostics, Merck KGaA, Darmstadt, Germany.
  • Bruns R; Biostatistics, Merck KGaA, Darmstadt, Germany.
  • Berghoff K; Global Patient Safety Innovation, Merck KGaA, Darmstadt, Germany.
  • Scheele J; Global Clinical Development Oncology, Merck KGaA, Darmstadt, Germany.
  • Raymond E; Medical Oncology, Paris-St Joseph Hospital, Paris, France.
  • Faivre S; Medical Oncology, Saint-Louis Hospital & Paris 7 University, Paris, France.
Br J Cancer ; 125(3): 465, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34079081

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França